Researchers at the University of Alabama at Birmingham have shown—for the first time—that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.
Jul 2, 2018
0
4341
Details of lung cell molecular pathways that promote or inhibit tissue regeneration were reported by researchers from the Perelmen School of Medicine at the University of Pennsylvania in Cell this week. Their aim is to find ...
Sep 7, 2017
0
18
University of Kentucky College of Nursing Assistant Professor Chizimuzo Okoli picked up his first and last cigarette when he was 6 years old.
Jan 12, 2017
0
0
Although there have been discussions about chronic obstructive pulmonary disease (COPD), a condition impacting 24 million Americans, and depression, there has been little research showing the impact depression has on patients ...
May 3, 2016
0
10
The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according ...
Feb 3, 2016
0
4
New research from an investigative team at the University of Cincinnati (UC) has identified biomarkers and potential therapeutic approaches that may hold the key to treating pulmonary alveolar microlithiasis (PAM), a rare ...
Nov 11, 2015
0
11
Researchers from the Department of Pulmonary Medicine and Sleep Disorders and All India Institute of Medical Sciences, New Delhi, India, studied the effects of yoga as a form of pulmonary rehabilitation on markers of inflammation ...
Oct 19, 2015
0
12
Researchers from The University of Texas Medical Branch at Galveston found that people with a psychological condition such as depression, anxiety, psychosis, or alcohol/drug abuse are more likely to be readmitted early into ...
Aug 13, 2015
0
10
(HealthDay)—A new anti-clotting drug to reduce the risk of dangerous blood clots and strokes in people with a type of heart rhythm disorder has been approved by the U.S. Food and Drug Administration.
Jan 9, 2015
0
35
A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection.
Sep 18, 2013
0
0
